Table 1.
Stimulus/substrate | Atherosclerotic | Metabolites formed: | ||
---|---|---|---|---|
6-keto-PGF1α | PGE2 | PGF2α | ||
Acetylcholine† | − | 121 ± 43 | 47 ± 13 | 31 ± 8 |
(100 nmol/L) | + | 48 ± 34* | 129 ± 64* | 41 ± 11 |
Angiotensin II† | − | 113 ± 61 | 57 ± 34 | 28 ± 11 |
(50 nmol/L) | + | 43 ± 27* | 108 ± 38* | 45 ± 21 |
Arachidonic acid† | − | 167 ± 67 | 115 ± 58 | 33 ± 8 |
(10 μmol/L) | + | 63 ± 27* | 188 ± 54* | 45 ± 15 |
14C-PGH2‡ | − | 75 ± 11 | 19 ± 11 | 4.5 ± 0.9 |
(100 μmol/L) | + | 31 ± 7* | 55 ± 14* | 5.4 ± 2.1 |
† Arteries were exposed to the stimuli for 30 minutes in an organ bath in the presence of 100 μmol/L N-methylarginine to inhibit NO formation. Prostanoids were extracted from the bath solution and quantitated by enzyme-linked immunosorbent assay. Data [in pg/mg wet tissue] represent means ± SEM from 10 independent experiments. Prostanoid release in unstimulated tissue was below the detection limit.
‡ Radiolabeled PGH2 was added to homogenized arteries. The percentage of conversion into different metabolites was determined after 3 minutes of incubation. Data [in percentage of 14C-PGH2 conversion] represent means ± SEM from seven independent experiments.
* P < 0.01 (atherosclerotic versus normal tissue).